Efficacy of plasma atherogenic index in predicting malignancy in the presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) prostate lesions.
Samet SenelKazım CevizYusuf KasapSedat TaştemurErkan OlcucuogluEmre UzunMuhammed Emin PolatAntonios KoudonasFirathan SarialtinPublished in: International urology and nephrology (2022)
PAI was found to be a predictive parameter for prostate cancer in PI-RADS 3 prostate lesions. Our study can open new thoughts about PAI as metric to assess the prostate cancer risk.